Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02513 is a long intergenic non-protein coding RNA gene in humans, annotated as producing non-coding RNA transcripts longer than 200 nucleotides that do not overlap protein-coding genes[1][3]. Like other lincRNAs, LINC02513 may play roles in fine-tuning the expression of neighboring genes, chromatin architecture, and transcriptional regulation, but its specific biological function, disease association, and details regarding molecular mechanisms remain largely uncharacterized in the scientific literature[1][3][7]. LINC02513 exemplifies the rapidly expanding class of lincRNAs that are recognized for their regulatory roles in the genome but are not usually considered receptors, enzymes, or conventional therapeutic targets[1][3][7]. Current data do not link LINC02513 to any drug interactions, mechanisms of action, or clinical biomarkers, and there are no known safety/toxicity issues relevant to therapy. The gene's primary relevance is in basic research relating to the non-coding transcriptome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2513 (LINC02513).